TERT mutation + BRAF V600E
|
Melanoma
|
TERT mutation + BRAF V600E
|
Melanoma
|
trametinib + dabrafenib Sensitive: D – Preclinical
|
trametinib + dabrafenib Sensitive: D – Preclinical
|
TERT mutation + BRAF V600E
|
Thyroid Gland Carcinoma
|
TERT mutation + BRAF V600E
|
Thyroid Gland Carcinoma
|
trametinib + dabrafenib Sensitive: D – Preclinical
|
trametinib + dabrafenib Sensitive: D – Preclinical
|
TERT mutation + BRAF V600E
|
Colon Cancer
|
TERT mutation + BRAF V600E
|
Colon Cancer
|
trametinib + dabrafenib Sensitive: D – Preclinical
|
trametinib + dabrafenib Sensitive: D – Preclinical
|